Podcast episode 23 (in German)
Metformin: From diabetes classic to longevity hope, fact-checked
July 5, 2026
Metformin is one of the oldest, cheapest and most prescribed medicines in the world and at the same time one of the most serious candidates for a longer, healthier life. The episode tells how the diabetes classic became a longevity hope, and what of it already holds up.
What it is about
Metformin has been the standard medicine for type 2 diabetes for decades: it throttles sugar production in the liver and makes cells more sensitive to insulin. Its roots go back to goat’s rue, a medicinal plant that was already used against diabetes in the Middle Ages. The longevity story begins with observations in people with diabetes who in some cases lived longer and healthier than expected on metformin. The episode explains the energy sensor AMPK, through which metformin simulates a mild energy deficit to the cell, similar to fasting or exercise, and the part of the effect that takes place in the gut. It clearly separates what is established in people with diabetes from what is still being tested in healthy people. The conclusion is a well-understood, inexpensive medicine with cautiously justified additional potential.
Key points
- In type 2 diabetes, after billions of prescriptions, metformin is among the best-studied medicines of all, with proven benefit for blood sugar, long-term complications and the cardiovascular system.
- Via the energy sensor AMPK, metformin simulates a mild energy deficit to the cell; the cell switches into a clean-up and protective mode with less inflammation and more cellular recycling.
- In observational studies, people with diabetes on metformin in some cases lived longer and healthier than expected, with fewer cardiovascular problems and in some cases fewer cases of certain cancers.
- The TAME trial, Targeting Aging with Metformin, is intended for the first time to study aging itself as a treatable target, with metformin as the test substance.
- A good part of the effect apparently takes place in the gut: metformin changes the interplay with the gut bacteria, which are closely linked to metabolism and inflammation.
- The most common side effect is gastrointestinal discomfort at the start, which often subsides; over the years, the absorption of vitamin B12 can decline, which can be monitored and corrected.
- Alongside rapamycin, the more potent but trickier longevity candidate, metformin is considered a well-tolerated all-rounder with a huge base of experience and a very low price.
Where the data stop
In healthy people who take metformin solely to extend life, the benefit is not proven. The indications come from observational data in people with diabetes, and targeted testing on aging is still pending, as of July 2026. If the effect is confirmed, it realistically means a gentle shift toward healthier aging, not a fountain of youth. For people who train a lot, there are indications that metformin can blunt part of the training adaptation because it pulls on similar switches as exercise itself.
Metformin is prescription-only. Taking it, especially for prevention, belongs in the hands of a physician, with attention to the kidneys, vitamin B12 and the personal situation.
Listen (in German)
Listen on Spotify Listen on Apple Podcasts Listen on Amazon Music
Published on July 5, 2026.
The topic in the database
- The proven, extremely inexpensive diabetes classic with a longevity bonus: activates AMPK like exercise and fasting – the TAME trial is currently testing the anti-aging…Metformin
All episodes in the app (German)
Information only, not medical advice and not a usage or dosage recommendation. Prescription-only and unapproved substances belong in the hands of a physician. Last updated: 2026-10-09.